April 2019 FDA Recall Drug by Johnson Matthey Inc.
D-1252-2019 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by Johnson Matthey Inc. on April 2, 2019 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1252-2019

Reason for Recall
Failed Impurities/Degradation Specifications: Unknown impurity above specification limits.
Initiated
04-02-2019
Reported
04-24-2019
Quantity
416.95 g glass container

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Johnson Matthey Inc.
Product was distributed to one manufacturer in Morgantown, WV who may have manufactured the product into finished product and further distribute to the retail level Nationwide in the USA.
Remifentanil HCl active pharmaceutical ingredient (API) for manufacturing, processing or repackaging, 416.95 g glass container, Rx ONLY, Johnson Matthey Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, NJ 08066-1742.

Batch or Lot Expiration Information

Lot# : B1319-170101